{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:14:42Z","timestamp":1789384482417,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The lung would be the first organ targeted in case of the use of Variola virus (the causative agent of smallpox) as a bioweapon. Pulmonary surfactant composed of lipids (90%) and proteins (10%) is considered the major physiological barrier against airborne pathogens. The principle phospholipid components of lung surfactant were examined in an <jats:italic>in vitro<\/jats:italic> model to characterize their interactions with VACV, a surrogate for variola virus. One of them, Dipalmitoyl phosphatidylglycerol (DPPG), was recently shown to inhibit VACV cell infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The interactions of poxvirus particles from the Western Reserve strain (VACV-WR) and the Lister strain (VACV-List) with model membranes for pulmonary surfactant phospholipids, in particular DPPG, were studied by Electron Spin Resonance (ESR) and proton Nuclear Magnetic Resonance (<jats:sup>1<\/jats:sup>H-NMR). ESR experiments showed that DPPG exhibits specific interactions with both viruses, while NMR experiments allowed us to deduce its stoichiometry and to propose a model for the mechanism of interaction at the molecular level.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These results confirm the ability of DPPG to strongly bind to VACV and suggest that similar interactions occur with variola virus. Similar studies of the interactions between lipids and other airborne pathogens are warranted.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1743-422x-7-379","type":"journal-article","created":{"date-parts":[[2011,1,19]],"date-time":"2011-01-19T19:19:17Z","timestamp":1295464757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["ESR and NMR studies provide evidence that phosphatidyl glycerol specifically interacts with poxvirus membranes"],"prefix":"10.1186","volume":"7","author":[{"given":"Jean-Claude","family":"Debouzy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Crouzier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Favier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Perino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,31]]},"reference":[{"key":"2567_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.virol.2005.09.037","volume":"344","author":"B Moss","year":"2006","unstructured":"Moss B: Poxvirus entry and membrane fusion. Virology. 2006, 344: 48-54. 10.1016\/j.virol.2005.09.037.","journal-title":"Virology"},{"key":"2567_CR2","first-page":"866","volume":"14","author":"IW Sherman","year":"2008","unstructured":"Sherman IW: Twelve diseases that changed our world. Emerg Infect Dis. 2008, 14: 866-","journal-title":"Emerg Infect Dis"},{"key":"2567_CR3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1096\/fasebj.8.12.8088461","volume":"8","author":"SA Rooney","year":"1994","unstructured":"Rooney SA, Young SL, Mendelson CR: Molecular and cellular processing of lung surfactant. FASEB J. 1994, 8: 957-967.","journal-title":"FASEB J"},{"key":"2567_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0925-4439(98)00061-1","volume":"1408","author":"R Veldhuizen","year":"1998","unstructured":"Veldhuizen R, Nag K, Orgeig S, Possmayer F: The role of lipids in pulmonary surfactant. Biochim Biophys Acta. 1998, 1408: 90-108.","journal-title":"Biochim Biophys Acta"},{"key":"2567_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.coph.2006.02.003","volume":"6","author":"PS Kingma","year":"2006","unstructured":"Kingma PS, Whitsett JA: In defense of the lung: surfactant protein A and surfactant protein D. Curr Opin Pharmacol. 2006, 6: 277-283. 10.1016\/j.coph.2006.02.003.","journal-title":"Curr Opin Pharmacol"},{"key":"2567_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1159\/000121454","volume":"93","author":"HP Haagsman","year":"2008","unstructured":"Haagsman HP, Hogenkamp A, van Eijk M, Veldhuizen EJ: Surfactant collectins and innate immunity. Neonatology. 2008, 93: 288-294. 10.1159\/000121454.","journal-title":"Neonatology"},{"key":"2567_CR7","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1194\/jlr.M600054-JLR200","volume":"47","author":"AD Postle","year":"2006","unstructured":"Postle AD, Gonzales LW, Bernhard W, Clark GT, Godinez MH, Godinez RI, Ballard PL: Lipidomics of cellular and secreted phospholipids from differentiated human fetal type II alveolar epithelial cells. J Lipid Res. 2006, 47: 1322-1331. 10.1194\/jlr.M600054-JLR200.","journal-title":"J Lipid Res"},{"key":"2567_CR8","doi-asserted-by":"publisher","first-page":"4858","DOI":"10.1128\/JVI.77.8.4858-4866.2003","volume":"77","author":"L Balakireva","year":"2003","unstructured":"Balakireva L, Schoehn G, Thouvenin E, Chroboczek J: Binding of adenovirus capsid to dipalmitoyl phosphatidylcholine provides a novel pathway for virus entry. J Virol. 2003, 77: 4858-4866. 10.1128\/JVI.77.8.4858-4866.2003.","journal-title":"J Virol"},{"key":"2567_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.virol.2004.01.020","volume":"322","author":"AL Favier","year":"2004","unstructured":"Favier AL, Burmeister WP, Chroboczek J: Unique physicochemical properties of human enteric Ad41 responsible for its survival and replication in the gastrointestinal tract. Virology. 2004, 322: 93-104. 10.1016\/j.virol.2004.01.020.","journal-title":"Virology"},{"key":"2567_CR10","volume-title":"Antiviral Res","author":"J Perino","year":"2010","unstructured":"Perino J, Crouzier D, Spehner D, Debouzy JC, Garin D, Crance JM, Favier AL: Lung surfactant DPPG phospholipid inhibits vaccinia virus infection. Antiviral Res. 2010"},{"key":"2567_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1006\/biol.1994.1025","volume":"22","author":"V Ludvikova","year":"1994","unstructured":"Ludvikova V, Kutinova L, Simonova V, Otavova M: Evaluation of various virulence tests with low virulence vaccinia virus in mice. Biologicals. 1994, 22: 187-190. 10.1006\/biol.1994.1025.","journal-title":"Biologicals"},{"key":"2567_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S1773-2247(05)50039-X","volume":"15","author":"Y Pailler","year":"2005","unstructured":"Pailler Y, Gadelle A, debouzy JC: hexakis (3,6-anhydro) tetrakis (2A,B,D,E-O-butyl) cyclomalto hexaose as a promising biological cation cryptant: Complexation and NMR study of interaction with membranes. Journal of drug delivery and science technology. 2005, 15: 237-244.","journal-title":"Journal of drug delivery and science technology"},{"key":"2567_CR13","first-page":"191","volume":"2","author":"M Mackett","year":"1985","unstructured":"Mackett M, Smith G, Moss B: The construction and characterization of vaccinia virus recombinants expressing foreign genes. DNA cloning: A Practical Approach. 1985, 2: 191-211.","journal-title":"DNA cloning: A Practical Approach"},{"key":"2567_CR14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/jvi.70.1.165-171.1996","volume":"70","author":"K Tsung","year":"1996","unstructured":"Tsung K, Yim JH, Marti W, Buller RM, Norton JA: Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light. J Virol. 1996, 70: 165-171.","journal-title":"J Virol"},{"key":"2567_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/BF00284727","volume":"17","author":"JC Debouzy","year":"1989","unstructured":"Debouzy JC, Neumann JM, Herve M, Daveloose D, Viret J, Apitz-Castro R: Interaction of antiaggregant molecule ajoene with membranes. An ESR and 1H, 2H, 31P-NMR study. Eur Biophys J. 1989, 17: 211-216. 10.1007\/BF00284727.","journal-title":"Eur Biophys J"},{"key":"2567_CR16","volume-title":"Flammarion m\u00e9decine Sciences Ed, Paris","author":"F Schwarz","year":"1981","unstructured":"Schwarz F: M\u00e9thodes statistiques \u00e0 l'usage des m\u00e9decins et biologistes. Flammarion m\u00e9decine Sciences Ed, Paris. 1981"},{"key":"2567_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-7643-7557-7_1","volume-title":"Poxviruses","author":"GL Smith","year":"2007","unstructured":"Smith GL: Genus Orthopoxvirus: vaccinia virus. Poxviruses. 2007, 1-45. full_text."},{"key":"2567_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1046\/j.1432-1033.2003.03924.x","volume":"271","author":"P Masson","year":"2004","unstructured":"Masson P, Goldstein BN, Debouzy JC, Froment MT, Lockridge O, Schopfer LM: Damped oscillatory hysteretic behaviour of butyrylcholinesterase with benzoylcholine as substrate. Eur J Biochem. 2004, 271: 220-234. 10.1046\/j.1432-1033.2003.03924.x.","journal-title":"Eur J Biochem"},{"key":"2567_CR19","volume-title":"Orlando, Academic Press","author":"D White","year":"1986","unstructured":"White D, Fenner F: Medical Virology (3rd Ed). Orlando, Academic Press. 1986"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-7-379.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T19:55:46Z","timestamp":1630612546000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-7-379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["2567"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-7-379","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"1 September 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"379"}}